Medinotec Inc (OTC: MDNC) is a medical device company that designs, manufactures, and sells minimally invasive surgical devices through its South African subsidiary, DISA Medinotec Proprietary Limited. Revenue comes from product sales directed primarily at hospital operating rooms in South Africa, with exports handled through distribution partnerships. As of the 10-K filed May 29, 2025, the company has three commercially available products and derives most of its profits from the South African market, relying heavily on DISA Life Sciences Proprietary Limited as its primary distribution and sales channel. The group operates a network of over 100 sales representatives covering approximately 60% of all hospital operating room floors on a weekly basis in South Africa. The company is pursuing regulatory clearance and market entry in North America. Its fiscal year ends February 28, with FY2025 results audited by Mercurius and Associates LLP and FY2024 results audited by BDO South Africa Inc.

Revenue model

Transactional product sales of proprietary minimally invasive surgical devices, sold through a distribution partnership with DISA Life Sciences Proprietary Limited in South Africa and historically through Minoan Medical for exports. The company has concentrated customer reliance on DISA Life Sciences for the South African market.

Products and services

Three commercially available minimally invasive surgical devices targeted at complex, specialized surgical cases in medical centers of excellence, plus a pipeline of developmental products. The company also invests in proprietary IP and in-house R&D and manufacturing capabilities.

Customers and end markets

Hospital operating rooms in South Africa are the primary end market, with healthcare providers and surgical centers as the key customer base. The company acknowledges material reliance on DISA Life Sciences Proprietary Limited as a customer. Third-party payers, including government programs and private insurers, influence procedure reimbursement and thus device demand.

Value-chain role

Manufacturer and IP developer of niche minimally invasive surgical devices, selling through an established third-party distribution network. The company conducts clinical trials as part of regulatory approval processes and maintains its own production facilities focused on cost reduction and equipment upgrades.

Geographic exposure

Primarily South Africa as of the 10-K filed May 29, 2025. The company has stated plans to enter the North American market but has not yet disclosed completed regulatory clearances or commercial sales in that region.

Source: SEC 10-K, filed 2025-05-29

Industry: Surgical & Medical Instruments & Apparatus